CEPI, THSTI and Panacea Biotec partner to develop broadly protective Betacoronavirus vaccines

Press Release - Panacea Biotec supplies 1st shipment of the second component of Sputnik V vaccine produced in India

Manufacturing cooperation is key to equitable access of vaccines across countries: Dr. Rajesh Jain - ETHealthWorldUpdated, July 15, 2021

Panacea Biotec receives licence to produce Sputnik V at Baddi, Business Line, chennai 05 July 2021

Press Release - Receipt of manufacturing license to produce Sputnik V

RDIF and Panacea Biotec launch the production of Sputnik V in India

Russian Direc Investment Fund and Panacea Biotec agree to produce 100 million doses of Sputnik V vaccine in India per year

‍

Press Release - Panacea Biotec announces successful completion of Phase I/II study of its novel, Tetravalent recombinant chimeric Dengue candidate vaccine, DengiAll

Press Release - Panacea Biotec and Refana announce landmark collaboration for Covid-19 vaccine

Press Release - Panacea Biotec Limited completes transfer of its Pharmaceuticals Business to its wholly owned subsidiary “Panacea Biotec Pharma Limited”

‍